Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Nat Neurosci. 2022 May;25(5):543-554. doi: 10.1038/s41593-022-01071-z. Epub 2022 May 6.
Eating disorders (anorexia nervosa, bulimia nervosa and binge-eating disorder) are a heterogeneous class of complex illnesses marked by weight and appetite dysregulation coupled with distinctive behavioral and psychological features. Our understanding of their genetics and neurobiology is evolving thanks to global cooperation on genome-wide association studies, neuroimaging, and animal models. Until now, however, these approaches have advanced the field in parallel, with inadequate cross-talk. This review covers overlapping advances in these key domains and encourages greater integration of hypotheses and findings to create a more unified science of eating disorders. We highlight ongoing and future work designed to identify implicated biological pathways that will inform staging models based on biology as well as targeted prevention and tailored intervention, and will galvanize interest in the development of pharmacologic agents that target the core biology of the illnesses, for which we currently have few effective pharmacotherapeutics.
进食障碍(神经性厌食症、神经性贪食症和暴食障碍)是一类复杂的疾病,其特征是体重和食欲失调,伴有独特的行为和心理特征。由于在全基因组关联研究、神经影像学和动物模型方面的全球合作,我们对其遗传学和神经生物学的理解正在不断发展。然而,到目前为止,这些方法平行地推动了该领域的发展,相互之间的交流不足。这篇综述涵盖了这些关键领域的重叠进展,并鼓励更深入地整合假设和发现,以创建一个更统一的进食障碍科学。我们强调了正在进行和未来的工作,旨在确定所涉及的生物学途径,这些途径将为基于生物学的分期模型以及有针对性的预防和个性化干预提供信息,并激发人们对开发针对这些疾病核心生物学的药物的兴趣,而目前我们对此类疾病的有效药物治疗方法却很少。